fbpx

Important notice:

AB Biotek Acquires Spanish Biomedical DR Healthcare

Respective leaders in fermentation science and DAO-based medical nutrition join together to focus on innovative enzyme-based solutions for the human nutrition & health market.

PETERBOROUGH, United Kingdom, May 26, 2021

+ more information

DR Healthcare

We are a Biomedical Company specialized in Medical Nutrition.

Founded in 2007 in Barcelona, ​​we manufacture, research, develop, innovate, market and carry out licensing -out of new nutraceutical products, functional foods, active ingredients and customized solutions.

Our great value is research and we firmly believe in the “Enterprise-University” alliance, developing our activities in two R&D centers.

DR Healthcare

We are a Biomedical Company specialized in Medical Nutrition.

Founded in 2007 in Barcelona, ​​we manufacture, research, develop, innovate, market and carry out licensing -out of new nutraceutical products, functional foods, active ingredients and customized solutions.

Our great value is research and we firmly believe in the “Enterprise-University” alliance, developing our activities in two R&D centers.

SGS-ISO 9001-COLOR
SGS-ISO 14001-COLOR

Manufacturing for third parties

DR Healthcare manufactures and markets the active substance (Diamine Oxidase – DAO enzyme) for third parties, both for human and animal use.

We make available to pharmaceutical and food companies that are looking for a reliable supplier, the highest levels of quality, regulatory support and production of Diamine Oxidase, manufactured in our enzyme production plant located in Tarragona (Spain).

The production of this ADI (Active Dietary Ingredient) is vertically integrated so it is able to control the intermediates of its manufacturing.

Customized solutions

DR Healthcare stands out as a leading company in the production of Diamino Oxidasa, which allows us to offer tailored solutions for use in the veterinary, animal health and food sectors.

Our solutions based on Diamino Oxidase are adapted to the new food control standards, which stipulate the control of histamine levels in order to avoid risks of poisoning due to the consumption of large amounts of this biogenic amine present in food.

 

Actuality

Press releases and media’s news

Migraine and DAO deficiency – el farmacéutico.es

You can download the supplement in pdf clicking in the image below or through here. (LANGUAGE: SPANISH) el farmacéutico.es publishes its supplement nº 585 entitled “Migraine and DAO deficiency (Diamine Oxidase)”. In this publication the scientific and clinical bases of migraine caused by DAO deficiency are exposed and the diagnostic methods...

Scientific and clinical evidence in DAO deficiency

Massive release of the histamine‐degrading enzyme diamine oxidase during severe anaphylaxis in mastocytosis patients

Download pdf Thomas Boehm, 1 Birgit Reiter, 2 Robin Ristl, 3 Karin Petroczi, 1 Wolfgang Sperr, 4 Thomas Stimpfl, 2 Peter Valent, 4 and Bernd Jilma 1 Allergy. 2019 Mar; 74(3): 583–593. Published online 2019 Jan 1. doi: 10.1111/all.13663     PMCID: PMC6590243    PMID: 30418682...

 Blog

Activities and events

26/03/2014 – European meeting of Pharmacy INFARMA 2014

Conference to be held on Wednesday 26 March at 16.30 h, “We are faced with a new syndrome? Digestive and neurological manifestations of the Deficit of DAO (Diaminooxidasa)” Act which will take place in IFEMA Madrid and will be in charge of Dr. Ramón tormo Carnice, Specialist in Gastroenterology and Head of the unit of Gastroenterology and Nutrition...
St/Escoles Píes, 49, 08017
DR HEALTHCARE ESPAÑA, S.L. (Barcelona, Spain)